Dr. Kaleb Lund of Herbal Analytics Awarded Research Grant From Bastyr University in Washington State for New Drug Discovery

MONTREAL, CANADA--(Marketwired - March 12, 2015) -

Editors Note: There is a photo associated with this press release.

Affinor Growers (CSE:AFI)(FRANKFURT:1AF)(OTCQB:RSSFF) ("Affinor" or the "Corporation) a diversified agriculture and biotechnology company with proprietary vertical farming systems, is pleased to announce that it's Washington State partner Kaleb Lund, Ph.D of Herbal Analytics has received a Faculty/Student Research Seed Grant for the proposal entitled "Standardization of Banisteriopsis caapi: Towards an FDA-approved Phase I Trial of Ayahuasca Tea in Healthy Adults." In collaboration with Leanna Standish, ND, Ph.D of Bastyr University, Dr. Lund and the Herbal Analytics team will be investigating extraction and standardization methods for the purposes of future botanical drug investigations using this sacred plant.

One of the purposes of the Research Seed Grant mechanism is to enable Herbal Analytics to perform a successful pilot study that will lead to a foundation or National Institutes of Health grant application.

Bastyr University is a regionally accredited, globally respected institution of natural health arts and sciences. They are improving the planet through innovative education, research and clinical service. The University has a primary campus in Kenmore, Washington, and a second campus in San Diego, California. Bastyr continues to be in the forefront of developing the model for 21st-century medicine.

"In my opinion this research grant awarded to our scientists and partners in Herbal Analytics opens the door for Affinor Growers to begin taking the steps to become a world leader in large scale drug discovery beginning in the Cannabis industry" commented Brusatore.

Affinor owns 49% of Herbal Analytics, a full service Drug Discovery and analytical consulting laboratory for botanical quality testing and natural product drug development. They are becoming a leader in the industry for guided intelligence in product development and safety testing for medical and recreational Cannabis products in the state of Washington.

Herbal Analytics has extensive herbal product industry experience with an edge using the most efficient and innovative analytical platforms for accurate and rapid results. Herbal Analytics chemical tests have been legitimized and proven, based on Bio Analytical Method Validation for accuracy and precision. The grant from Bastyr University is a major step toward developing products for specific plant and standardization for efficacy.

About Affinor Growers Inc.

Affinor Growers is a diversified publicly traded company on the Canadian Securities Exchange under the symbol ("AFI"). Affinor is focused on growing high quality crops such as romaine lettuce, spinach, strawberries and high quality medical Marijuana. Affinor is committed to becoming a pre-eminent grower, using exclusive vertical farming techniques.

On Behalf of the Board of Directors

AFFINOR GROWERS INC.

Sebastien Plouffe, President & CEO

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

FORWARD-LOOKING INFORMATION

This News Release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents which can be found under the Company's profile on www.sedar.com. This News Release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

To view the photo associated with this press release, please visit the following link: http://www.marketwire.com/library/20150311-NickBrusatore.jpg